Ortin Laboratories Limited Stock Current Valuation
| ORTINLAB | 19.63 0.00 0.00% |
Valuation analysis of Ortin Laboratories helps investors to measure Ortin Laboratories' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Ortin Laboratories' Cash is projected to decrease significantly based on the last few years of reporting. The current year's Cash And Short Term Investments is expected to grow to about 24.6 M, whereas Free Cash Flow is projected to grow to (39.5 M). Fundamental drivers impacting Ortin Laboratories' valuation include:
Price Book 5.6524 | Enterprise Value 156 M | Enterprise Value Ebitda (6.42) | Price Sales 22.1084 | Enterprise Value Revenue 8.338 |
Overvalued
Today
Please note that Ortin Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Ortin Laboratories is based on 3 months time horizon. Increasing Ortin Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ortin Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ortin Stock. However, Ortin Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.63 | Real 17.02 | Hype 19.63 |
The real value of Ortin Stock, also known as its intrinsic value, is the underlying worth of Ortin Laboratories Company, which is reflected in its stock price. It is based on Ortin Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ortin Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ortin Laboratories Limited helps investors to forecast how Ortin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ortin Laboratories more accurately as focusing exclusively on Ortin Laboratories' fundamentals will not take into account other important factors: Ortin Laboratories Limited Company Current Valuation Analysis
Ortin Laboratories' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ortin Laboratories Current Valuation | 155.99 M |
Most of Ortin Laboratories' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ortin Laboratories Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Ortin Laboratories Limited has a Current Valuation of 155.99 M. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is notably lower than that of the firm.
Ortin Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ortin Laboratories' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ortin Laboratories could also be used in its relative valuation, which is a method of valuing Ortin Laboratories by comparing valuation metrics of similar companies.Ortin Laboratories is currently under evaluation in current valuation category among its peers.
Ortin Fundamentals
| Return On Equity | -1.17 | ||||
| Return On Asset | -0.3 | ||||
| Operating Margin | (0.50) % | ||||
| Current Valuation | 155.99 M | ||||
| Shares Outstanding | 8.13 M | ||||
| Shares Owned By Insiders | 27.31 % | ||||
| Price To Book | 5.65 X | ||||
| Price To Sales | 22.11 X | ||||
| Revenue | 21.11 M | ||||
| Gross Profit | 25.39 M | ||||
| EBITDA | (65.37 M) | ||||
| Net Income | (80.41 M) | ||||
| Total Debt | 18.02 M | ||||
| Book Value Per Share | 3.48 X | ||||
| Cash Flow From Operations | (41.53 M) | ||||
| Earnings Per Share | (10.04) X | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 165.64 M | ||||
| Total Asset | 66.64 M | ||||
| Retained Earnings | 20.88 M | ||||
| Working Capital | (4.44 M) | ||||
| Net Asset | 66.64 M |
About Ortin Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ortin Laboratories Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ortin Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ortin Laboratories Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ortin Stock
Ortin Laboratories financial ratios help investors to determine whether Ortin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ortin with respect to the benefits of owning Ortin Laboratories security.